Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins
摘要:
A midthroughput screening follow-up program targeting the first bromodomain of the human BRD4 protein, BRD4(BD1), identified an acetylated-mimic xanthine derivative inhibitor. This compound binds with an affinity in the low micromolar range yet exerts suitable unexpected selectivity in vitro against the other members of the bromodomain and extra-terminal domain (BET) family. A structure-based program pinpointed a role of the ZA loop, paving the way for the development of potent and selective BET-BRDi probes.
[EN] XANTHINE DERIVATIVE INHIBITORS OF BET PROTEINS<br/>[FR] DÉRIVÉS DE XANTHINE INHIBITEURS DE PROTÉINES BET
申请人:INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE)
公开号:WO2017114843A1
公开(公告)日:2017-07-06
This invention relates to xanthine derivative compounds that are inhibitors of BET bromodomains proteins, the method of preparation thereof and applications thereof.
This invention relates to xanthine derivative compounds that are inhibitors of BET bromodomains proteins, the method of preparation thereof and applications thereof.